These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6176687)

  • 1. In vitro skeletal muscle protein and RNA incorporation in neuromuscular disease.
    Tomkins JK; Collins SP; Baker WD; Kidman AD
    J Neurol Sci; 1982 Apr; 54(1):59-68. PubMed ID: 6176687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical study of connectin (titin) in neuromuscular diseases using a monoclonal antibody: connectin is degraded extensively in Duchenne muscular dystrophy.
    Matsumura K; Shimizu T; Nonaka I; Mannen T
    J Neurol Sci; 1989 Nov; 93(2-3):147-56. PubMed ID: 2592979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization and characterization of dystrophin in muscle biopsy specimens from Duchenne muscular dystrophy and various neuromuscular disorders.
    Uchino M; Araki S; Miike T; Teramoto H; Nakamura T; Yasutake T
    Muscle Nerve; 1989 Dec; 12(12):1009-16. PubMed ID: 2695839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic studies of muscle proteins in Duchenne muscular dystrophy and other neuromuscular disorders--with special reference to the change of dystrophin.
    Uchino M; Araki S; Miike T
    Jpn J Med; 1989; 28(2):170-4. PubMed ID: 2659855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbindin, syncoilin, and beta-synemin mRNA levels in dystrophic muscles.
    Wakayama Y; Matsuzaki Y; Yamashita S; Inoue M; Jimi T; Hara H; Unaki A; Iijima S; Masaki H
    Int J Neurosci; 2010 Feb; 120(2):144-9. PubMed ID: 20199207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophin and nebulin in the muscular dystrophies.
    Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V
    J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
    Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pentose phosphate pathway in neuromuscular diseases--evaluation of muscular glucose 6-phosphate dehydrogenase activity and RNA content].
    Konagaya M; Konagaya Y; Horikawa H; Iida M
    Rinsho Shinkeigaku; 1990 Oct; 30(10):1078-83. PubMed ID: 1703936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of serum myoglobin in neuromuscular diseases and in carrier detection of Duchenne muscular dystrophy.
    Nørregaard-Hansen K; Hein-Sørensen O
    Acta Neurol Scand; 1982 Aug; 66(2):259-66. PubMed ID: 7136489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative damage to muscle protein in Duchenne muscular dystrophy.
    Haycock JW; MacNeil S; Jones P; Harris JB; Mantle D
    Neuroreport; 1996 Dec; 8(1):357-61. PubMed ID: 9051810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle carnitine levels in neuromuscular disease.
    Borum PR; Broquist HP; Roelops RJ
    J Neurol Sci; 1977 Nov; 34(2):279-86. PubMed ID: 925714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle calcium and magnesium content in Duchenne muscular dystrophy.
    Bertorini TE; Bhattacharya SK; Palmieri GM; Chesney CM; Pifer D; Baker B
    Neurology; 1982 Oct; 32(10):1088-92. PubMed ID: 6889695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in lipid incorporation in Duchenne muscular dystrophy. Studies of fresh and cultured muscle.
    Ionasescu V; Monaco L; Sandra A; Ionasescu R; Burmeister L; Deprosse C; Stern LZ
    J Neurol Sci; 1981 May; 50(2):249-51. PubMed ID: 7229668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of myoglobin gene in skeletal muscle of patients with neuromuscular diseases.
    Kawai H; Naruo T; Yoneda K; Masuda K; Mitsui T; Nishida Y
    Muscle Nerve; 1994 Jul; 17(7):720-4. PubMed ID: 8007996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofibrillar incorporation of 3H (G) L-leucine in pgrogressive muscular dystrophy and motor neuron disease.
    Monckton G; Marusyk H
    Neurology; 1976 Mar; 26(3):234-7. PubMed ID: 943052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV; Davison K; Johnson MA; Slater CR; Young C; Bhattacharya S; Gardner-Medwin D; Harris JB
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin immunostaining of muscle from Chinese patients with various neuromuscular diseases.
    Jong YJ; Chuang YH; Chen SS; Chen BH; Chiang CH
    J Formos Med Assoc; 1991 Dec; 90(12):1143-8. PubMed ID: 1686882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.